Following the deadline for the submission of abstracts to the 2021 meeting, we have now made a tentative program for the meeting. All presenters will be contacted within the next few days and asked to confirm their presentation.

The meeting will take place as a virtual meeting from 12.30-16.00 CET on April 21st and 22nd. Registration to the meeting will open mid february, and more information on this will be provided at that time.

The tentative program overview:

Wednesday April 21st      12.30-16.00

12.30-13.40:         Session I: Welcome and situation updates   

14.15-15.00:         Session II: Experience from the field 

15.15-16.00:         Session III: CMS –host interaction and diagnostic potential      

Thursday April 22nd     12.30-16.00 

12.30-13.30:         Session IV: Molecular epidemiology   

13:45-14:10:         Intermission:Information from TriNation and our sponsors

14.10-15.15:         Session V: Vaccine development        

15.15-16.00:         Session VI: Vaccine evaluation